Top Markets
#1 Islamic Coin Islamic Coin +151.45%
#2 DOVU DOVU +49.92%
#3 Velvet Velvet +41.51%
#4 Black Phoenix Black Phoenix +34.92%
#5 Palladium Network Palladium Network +21.70%
#6 Fake World Assets Fake World Assets +19.35%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.99%
#8 DoubleZero DoubleZero +18.67%
#9 Akedo Akedo +18.04%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +13.01%
Coin of the day
Islamic Coin Islamic Coin
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Arecor Therapeutics plc Arecor Therapeutics plc

Arecor Therapeutics plc

AREC
Pozycja w akcjach #39891
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating... Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and collaborate with pharmaceutical and biotechnology partners to refine and enhance existing therapeutic formulations. Its pipeline includes AT247, an exceptionally fast-acting insulin aimed at individuals with Type I and Type II diabetes, and AT278, a highly concentrated rapid-acting insulin formulation engineered to hasten insulin absorption following injection. Established in 2007, the company's main office is situated in Little Chesterford, United Kingdom.
Cena akcji
$0.80961743
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$305.68K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-5.76%
Kraj
GB
Handel Arecor Therapeutics plc (AREC)

Kategoria

Healthcare
Zyski dla Arecor Therapeutics plc (AREC)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Arecor Therapeutics plc, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Arecor Therapeutics plc od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE